Pilot Clinical Trials Testing the Safety and Effects on the Metastatic Melanoma Microenvironment of Intratumoral Interferon-Gamma or Imiquimod, Plus a Multipeptide Melanoma Vaccine
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-3-s2-p139
Full Text
Open PDFAbstract
Available in full text
Date
November 4, 2015
Authors
Publisher
BMJ